Bile acid secretion and pool size during phenobarbital induced hypercholeresis

Area of Science:

• Hepatology
• Pharmacology
• Gastroenterology

Background:

• Phenobarbital administration is known to increase bile flow in rats.
• The precise mechanisms driving this choleretic effect and the role of increased liver weight remain unclear.
• Hepatomegaly following phenobarbital treatment has been attributed to both cellular hypertrophy and hyperplasia.

Purpose of the Study:

• To investigate the mechanisms of phenobarbital-induced choleresis.
• To clarify the contribution of hepatocyte hypertrophy versus hyperplasia to increased liver weight.
• To determine the impact of phenobarbital on bile acid secretion and bile flow.

Main Methods:

• Male Sprague-Dawley rats were administered phenobarbital (75 mg/kg/day) for six days.
• Measurements included bile flow, bile acid secretion rate, bile acid pool size, liver weight, hepatocyte volume, and liver DNA content.
• Bile flow was normalized to body weight and liver weight.

Main Results:

• Phenobarbital significantly increased liver weight (39%) and mean hepatocyte volume (26%), indicating hypertrophy rather than hyperplasia (DNA content unchanged).
• Bile flow per unit body weight was higher in treated rats, but bile flow per gram of liver remained unchanged.
• Bile acid secretion rate and pool size were significantly reduced in phenobarbital-treated rats.

Conclusions:

• Phenobarbital-induced hepatomegaly primarily results from hepatocyte hypertrophy.
• The observed increase in bile flow (choleresis) is mainly due to an expansion of the bile acid-independent fraction.
• Enlarged hepatocytes in phenobarbital-treated rats produce more bile despite reduced bile acid secretion.